Old API Wind-down Ltd. Stock

Stocks

ARLZQ

CA03852X1006

Pharmaceuticals

OTC Markets Traded
Delayed OTC Markets 5-day change 1st Jan Change
- USD -.--% Intraday chart for Old API Wind-down Ltd. -.--% -

Valuation: Old API Wind-down Ltd.

Market Cap 87.35K 76.4K 70.12K 65.45K 124K 8.32M 126K 842K 327K 4.08M 328K 321K 14.09M P/E 2016
-2.53x
P/E 2017 -0.75x
Enterprise Value 246M 215M 197M 184M 349M 23.39B 354M 2.37B 921M 11.49B 923M 903M 39.65B EV / Sales 2016
9.18x
EV / Sales 2017 3.22x
Free-Float
100%
Yield 2016 *
-
Yield 2017 -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 0
+1.86%+0.48%+55.50%+163.08% 1,082B
+3.57%+3.29%+68.60%+61.03% 633B
+3.99%+3.05%+37.93%+93.37% 461B
+3.86%+1.64%+32.57%+24.89% 338B
-0.56%+0.96%+41.67%+39.35% 299B
-0.08%+1.30%+32.15%+44.48% 291B
-1.54%+2.81%-25.35%-39.61% 222B
+3.55%+4.41%+25.45%+66.28% 202B
+4.21%+2.65%+17.47%+71.11% 163B
Average +1.89%+4.12%+31.78%+58.22% 369.24B
Weighted average by Cap. +2.25%+5.53%+42.31%+83.31%

Financials

2016 2017
Net sales 54.27M 47.46M 43.56M 40.66M 77.05M 5.17B 78.2M 523M 203M 2.54B 204M 199M 8.76B 106M 92.66M 85.04M 79.39M 150M 10.09B 153M 1.02B 397M 4.95B 398M 389M 17.09B
Net income -103M -90.06M -82.66M -77.16M -146M -9.8B -148M -993M -386M -4.81B -387M -378M -16.61B -125M -110M -101M -93.82M -178M -11.92B -180M -1.21B -469M -5.85B -470M -460M -20.2B
Net Debt 209M 183M 168M 157M 297M 19.94B 302M 2.02B 785M 9.79B 787M 769M 33.8B 246M 215M 197M 184M 349M 23.39B 354M 2.37B 921M 11.49B 922M 902M 39.63B
Logo Old API Wind-down Ltd.
Old API Wind-Down Ltd, formerly Aralez Pharmaceuticals Inc., is a Canada-based specialty pharmaceutical company. The Company focuses on acquiring, developing and commercializing products in cardiovascular, pain and other areas. The Company's products include Fibricor, Cambia, Fiorinal, Fiorinal C, Soriatane, Bezalip SR, NeoVisc, Uracyst, Durela, Proferrin, Resultz and Collatamp G. Its development products include YOSPRALA and Bilastine. Fibricor (fenofibric acid) is indicated as a complementary therapy along with diet for the treatment of hypertriglyceridemia, and as a complementary therapy along with diet to reduce elevated low-density lipoprotein cholesterol (LDL-C), total cholesterol (Total-C), triglycerides (TG) and apolipoprotein B (Apo B). Fibricor is also used to increase high-density lipoprotein (HDL) cholesterol (HDL-C) in patients with hypercholesterolemia or mixed dyslipidemia. Cambia (diclofenac potassium for oral solution) is a non-steroidal anti-inflammatory drug (NSAID).
Employees
-
  1. Stock Market
  2. Stocks
  3. ARLZQ Stock